Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Commercial Officer
-
Stock Symbol
-
CYTK on Nasdaq
Andrew Callos - trading volume in the past year for Cytokinetics Inc
Holdings reported by Andrew Callos for Cytokinetics Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
64.7K |
$2.31M |
$35.78 |
Apr 7, 2025 |
Direct |
|
|
| Incentive Stock Option (Right to Buy) |
2.75K |
$103K |
$37.63 |
Mar 14, 2025 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (Right to Buy) |
129K |
|
|
Mar 17, 2025 |
Direct |
Common Stock |
|
Transactions reported by Andrew Callos for Cytokinetics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.